SCHEMBL6099031

SCHEMBL6099031

CC(C)(C)OC(=O)N1CCN(Cc2ccccc2)CC1Cc1ccc(Cl)cc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 2/20 0.54
NR1H3 Q13133 2/20 0.54
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CA4 P22748 2/20 0.50
CA9 Q16790 2/20 0.50
PARP1 P09874 1/20 0.48
TP53 P04637 1/20 0.48
THRB P10828 1/20 0.48
DPP4 P27487 2/20 0.47
HDAC1 Q13547 1/20 0.47
DPP7 Q9UHL4 1/20 0.46
SIGMAR1 Q99720 1/20 0.46
ALDH1A1 P00352 2/20 0.44
DRD4 P21917 1/20 0.44
ROCK1 Q13464 1/20 0.44
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5369120 1.00 NR1H2 (0.54) NR1H2NR1H3CA1CA2CA4
SCHEMBL6099695 0.94 NR1H2 (0.58) NR1H2NR1H3CA1CA2CA4
SCHEMBL8448438 0.94 NR1H2 (0.58) NR1H2NR1H3CA1CA2CA4
SCHEMBL8229118 0.92 NR1H2 (0.54) NR1H2NR1H3CA1CA2CA4
SCHEMBL3495123 0.92 NR1H2 (0.54) NR1H2NR1H3CA1CA2CA4
SCHEMBL3506136 0.92 NR1H2 (0.54) NR1H2NR1H3CA1CA2CA4
SCHEMBL13705076 0.91 NR1H2 (0.53) NR1H2NR1H3CA1CA2CA4
SCHEMBL5378968 0.89 LMNA (0.53) NR1H2NR1H3CA1CA2CA4
SCHEMBL6098997 0.89 NR1H2 (0.52) NR1H2NR1H3CA1CA2CA4
SCHEMBL3506688 0.88 NR1H2 (0.51) NR1H2NR1H3CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7094779-B2 Piperazine oxime dervatives having NK-1 receptor antagonistic activity SOLVAY PHARMACEUTICALS B.V. (NL) 2006-08-22 US disclosed